Factors associated with the occurrence, resolution, and recurrence of tender psoriatic dactylitis: Results from a longitudinal cohort study
Therapeutic Advances in Musculoskeletal Disease · 2026-08 · 18
DOI: 10.1177/1759720x261506733 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Therapeutic Advances in Musculoskeletal Disease, online erschienen am 19.11.2026. Verfasst von Fadi Kharouf und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Krembil Foundation, The Schroeder Arthritis Institute, UHN.
Abstract (Originalsprache)
Background
Tender (acute) dactylitis is a hallmark manifestation of psoriatic arthritis (PsA), yet longitudinal data on its clinical course and management remain limited.
Objectives
We aimed to investigate the clinical factors associated with tender psoriatic dactylitis and examine the associations of different treatment modalities with its occurrence, resolution, and recurrence.
Design
Retrospective longitudinal cohort study based on prospectively collected data.
Methods
We included patients with PsA from a prospective observational cohort. We used univariable and multivariable generalized estimating equations (GEE), adjusted for calendar decade, to examine clinical factors associated with tender dactylitis. Additionally, we employed univariable and multivariable parametric survival models, adjusted for calendar decade and accounting for interval-censored data, to investigate factors influencing the time to resolution and recurrence of tender dactylitis.
Results
Of the 1725 patients included in this study, 639 (37.0%) had at least one episode of tender dactylitis over a median follow-up of 8.9 years [2.4, 16.5]. In multivariable analyses, tender dactylitis was significantly associated with male sex (odds ratio [OR] 3.07, 95% confidence interval [CI] 1.30–7.24) and higher cDAPSA score (OR 1.05, 95% CI 1.03–1.07). In contrast, biologic or targeted synthetic DMARD (b/tsDMARDs) use was inversely associated (OR 0.29, 95% CI 0.13–0.64). Importantly, b/tsDMARD use for managing tender dactylitis was associated with more rapid resolution (HR 1.52, 95% CI 1.04–2.21) and longer time to recurrence (HR 0.51, 95% CI 0.27–0.97), whereas glucocorticoid injections and conventional synthetic DMARDs showed no significant association.
Conclusion
Tender dactylitis is common in PsA and is associated with a more severe disease phenotype. In this longitudinal observational cohort, b/tsDMARD use was associated with a lower occurrence of tender dactylitis and more favorable resolution and recurrence outcomes; however, residual confounding by indication cannot be excluded.
Förderung
- Krembil Foundation
- The Schroeder Arthritis Institute
- UHN
Zitieren
APA
Kharouf, F., Mehta, P., Abarza, V. C., Gao, S., Pereira, D., Chandran, V., Gladman, D. D., & Poddubnyy, D. (2026). Factors associated with the occurrence, resolution, and recurrence of tender psoriatic dactylitis: Results from a longitudinal cohort study. Therapeutic Advances in Musculoskeletal Disease, 18. https://doi.org/10.1177/1759720x261506733
Vancouver
Kharouf F, Mehta P, Abarza VC, Gao S, Pereira D, Chandran V, et al. Factors associated with the occurrence, resolution, and recurrence of tender psoriatic dactylitis: Results from a longitudinal cohort study. Therapeutic Advances in Musculoskeletal Disease. 2026;18. doi:10.1177/1759720x261506733
BibTeX
@article{Kharouf2026,
author = {Kharouf, Fadi and Mehta, Pankti and Abarza, Virginia Carrizo and Gao, Shangyi and Pereira, Daniel and Chandran, Vinod and Gladman, Dafna D. and Poddubnyy, Denis},
title = {Factors associated with the occurrence, resolution, and recurrence of tender psoriatic dactylitis: Results from a longitudinal cohort study},
journal = {Therapeutic Advances in Musculoskeletal Disease},
year = {2026},
volume = {18},
doi = {10.1177/1759720x261506733}
}
EUVIMED